Transplant
Conference Coverage
Chronic GVHD therapies offer hope for treating refractory disease
Guidelines
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
From the Journals
Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant
But only if caregivers are equipped for outpatient care.
From the Journals
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
‘Practice changing’: Ruxolitinib as second-line in chronic GVHD
Conference Coverage
Allogeneic transplant leads to durable remissions in T-cell lymphomas
Retrospective study demonstrates overall survival over 50% at 5 years, though transplant-related mortality and graft-versus-host disease need to...
Feature
Can receiving HSCT care at home reduce the risk of GVHD and COVID-19?
Researchers are studying whether receiving posttransplant care at home can improve outcomes.
Conference Coverage
Prevention of HMA failure a goal for high-risk MDS posttransplant
Conference Coverage
Are HMAS appropriate for posttransplant maintenance in acute leukemias?
Not yet, hematologist/oncologist tells colleagues at ALF meeting.
Conference Coverage
Novel treatments under study for chronic graft-versus-host disease in allo-HCT
Conference Coverage
Can AML patients be too old for cell transplantation?